David Schnell October 2, 2017 October 2, 2017 - NGM Study Published in Nature Reveals Molecular Pathway of Weight-Controlling Hormone, Enabling the Discovery of Multiple Drug Candidates for Obesity and Cachexia David Schnell October 2, 2017
David Schnell September 11, 2017 Sept 11, 2017 - Insmed Announces Closing of Public Offering David Schnell September 11, 2017
David Schnell September 5, 2017 Sep 5, 2017 - Insmed Announces Positive Top-Line Results from Phase 3 CONVERT Study of ALIS (Amikacin Liposome Inhalation Suspension) in Adult Patients with Treatment-Refractory (NTM) Lung Disease David Schnell September 5, 2017
David Schnell June 7, 2017 June 7, 2017 - SentreHEART aMAZE Trial Receives FDA Approval for Stage II David Schnell June 7, 2017
David Schnell May 16, 2017 May 16, 2017 - Nanosys Hyperion Quantum Dot Technology Wins Display Component of the Year Award at DisplayWeek 2017 David Schnell May 16, 2017
David Schnell May 15, 2017 May 15, 2017 - Insmed Announces Key Additions to its Executive Management Team David Schnell May 15, 2017
David Schnell May 5, 2017 May 5, 2017- NinePoint Medical to Feature the NvisionVLE® Imaging System with Real-time Targeting™ at DDW 2017; Twenty-four Scientific Abstracts to be Presented David Schnell May 5, 2017
David Schnell April 24, 2017 April 24, 2017 - Merck-backed NGM Bio hits its marks in midstage NASH trial David Schnell April 24, 2017
David Schnell April 22, 2017 April 22, 2017 - NGM Bio Announces NGM282 Dramatically Reduced Liver Fat and Other Biomarkers Associated with Nonalcoholic Steatohepatitis (NASH) in Phase 2 Trial David Schnell April 22, 2017
David Schnell March 16, 2017 March 16, 2017 - Nanosys and Exciton Technology Partner to Accelerate Adoption of Quantum Dot Technology For Displays in China David Schnell March 16, 2017
David Schnell February 14, 2017 Febuary 14, 2017 - Insmed Inc. Extends ARIKAYCE Intellectual Property Protection with Issuance of New U.S. Patent David Schnell February 14, 2017